{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:49:35Z","timestamp":1789955375882,"version":"4.0.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T00:00:00Z","timestamp":1538438400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s11892-018-1072-7","type":"journal-article","created":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T08:40:02Z","timestamp":1538469602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Can We Re-Engineer the Endocrine Pancreas?"],"prefix":"10.1007","volume":"18","author":[{"given":"Antonio","family":"Citro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald C.","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,2]]},"reference":[{"key":"1072_CR1","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/nature08933","volume":"464","author":"JA Bluestone","year":"2010","unstructured":"Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature. 2010;464:1293\u2013300.","journal-title":"Nature"},{"key":"1072_CR2","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.2337\/db10-1797","volume":"60","author":"MA Atkinson","year":"2011","unstructured":"Atkinson MA, Bluestone JA, Eisenbarth GS, Hebrok M, Herold KC, Accili D, et al. How does type 1 diabetes develop?: the notion of homicide or beta-cell suicide revisited. Diabetes. 2011;60:1370\u20139.","journal-title":"Diabetes"},{"key":"1072_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1089\/ten.teb.2011.0004","volume":"17","author":"JY Cheng","year":"2011","unstructured":"Cheng JY, Raghunath M, Whitelock J, Poole-Warren L. Matrix components and scaffolds for sustained islet function. Tissue Eng B Rev. 2011;17:235\u201347.","journal-title":"Tissue Eng B Rev"},{"key":"1072_CR4","first-page":"E43","volume":"249","author":"N Lifson","year":"1985","unstructured":"Lifson N, Lassa CV, Dixit PK. Relation between blood flow and morphology in islet organ of rat pancreas. Am J Phys. 1985;249:E43\u20138.","journal-title":"Am J Phys"},{"key":"1072_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3109\/03009734.2016.1164769","volume":"121","author":"L Jansson","year":"2016","unstructured":"Jansson L, Barbu A, Bodin B, Drott CJ, Espes D, Gao X, et al. Pancreatic islet blood flow and its measurement. Ups J Med Sci. 2016;121:81\u201395.","journal-title":"Ups J Med Sci"},{"key":"1072_CR6","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s00125-005-1865-5","volume":"48","author":"MM Zanone","year":"2005","unstructured":"Zanone MM, Favaro E, Doublier S, Lozanoska-Ochser B, Deregibus MC, Greening J, et al. Expression of nephrin by human pancreatic islet endothelial cells. Diabetologia. 2005;48:1789\u201397.","journal-title":"Diabetologia"},{"key":"1072_CR7","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00125-002-0827-4","volume":"45","author":"L Jansson","year":"2002","unstructured":"Jansson L, Carlsson PO. Graft vascular function after transplantation of pancreatic islets. Diabetologia. 2002;45:749\u201363.","journal-title":"Diabetologia"},{"key":"1072_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1210\/er.2009-0035","volume":"31","author":"OC Richards","year":"2010","unstructured":"Richards OC, Raines SM, Attie AD. The role of blood vessels, endothelial cells, and vascular pericytes in insulin secretion and peripheral insulin action. Endocr Rev. 2010;31:343\u201363.","journal-title":"Endocr Rev"},{"key":"1072_CR9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1369\/0022155415583535","volume":"63","author":"MF Brereton","year":"2015","unstructured":"Brereton MF, Vergari E, Zhang Q, Clark A. Alpha-, delta- and PP-cells: are they the architectural cornerstones of islet structure and co-ordination? J Histochem Cytochem. 2015;63:575\u201391.","journal-title":"J Histochem Cytochem"},{"key":"1072_CR10","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00268-006-0719-8","volume":"31","author":"N Ballian","year":"2007","unstructured":"Ballian N, Brunicardi FC. Islet vasculature as a regulator of endocrine pancreas function. World J Surg. 2007;31:705\u201314.","journal-title":"World J Surg"},{"key":"1072_CR11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s11892-013-0401-0","volume":"13","author":"A Citro","year":"2013","unstructured":"Citro A, Cantarelli E, Piemonti L. Anti-inflammatory strategies to enhance islet engraftment and survival. Current Diabetes Reports. 2013;13:733\u201344.","journal-title":"Current Diabetes Reports"},{"key":"1072_CR12","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1097\/TP.0000000000001462","volume":"101","author":"E Cantarelli","year":"2017","unstructured":"Cantarelli E, Citro A, Pellegrini S, Mercalli A, Melzi R, Dugnani E, et al. Transplant site influences the immune response after islet transplantation: bone marrow versus liver. Transplantation. 2017;101:1046\u201355.","journal-title":"Transplantation"},{"key":"1072_CR13","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1172\/JCI63089","volume":"122","author":"A Citro","year":"2012","unstructured":"Citro A, Cantarelli E, Maffi P, Nano R, Melzi R, Mercalli A, et al. CXCR1\/2 inhibition enhances pancreatic islet survival after transplantation. J Clin Invest. 2012;122:3647\u201351.","journal-title":"J Clin Invest"},{"key":"1072_CR14","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/TP.0000000000001925","volume":"102","author":"A Citro","year":"2018","unstructured":"Citro A, Cantarelli E, Pellegrini S, Dugnani E, Piemonti L. Anti-inflammatory strategies in intrahepatic islet transplantation: a comparative study in preclinical models. Transplantation. 2018;102:240\u20138.","journal-title":"Transplantation"},{"key":"1072_CR15","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2337\/db12-0432","volume":"62","author":"E Korpos","year":"2013","unstructured":"Korpos E, Kadri N, Kappelhoff R, Wegner J, Overall CM, Weber E, et al. The peri-islet basement membrane, a barrier to infiltrating leukocytes in type 1 diabetes in mouse and human. Diabetes. 2013;62:531\u201342.","journal-title":"Diabetes"},{"key":"1072_CR16","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.2337\/db05-1388","volume":"55","author":"G Parnaud","year":"2006","unstructured":"Parnaud G, Hammar E, Rouiller DG, Armanet M, Halban PA, Bosco D. Blockade of beta1 integrin-laminin-5 interaction affects spreading and insulin secretion of rat beta-cells attached on extracellular matrix. Diabetes. 2006;55:1413\u201320.","journal-title":"Diabetes"},{"key":"1072_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3727\/096368909788237195","volume":"18","author":"JC Stendahl","year":"2009","unstructured":"Stendahl JC, Kaufman DB, Stupp SI. Extracellular matrix in pancreatic islets: relevance to scaffold design and transplantation. Cell Transplant. 2009;18:1\u201312.","journal-title":"Cell Transplant"},{"key":"1072_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/BF00318700","volume":"267","author":"JH Deijnen van","year":"1992","unstructured":"van Deijnen JH, Hulstaert CE, Wolters GH, van Schilfgaarde R. Significance of the peri-insular extracellular matrix for islet isolation from the pancreas of rat, dog, pig, and man. Cell Tissue Res. 1992;267:139\u201346.","journal-title":"Cell Tissue Res"},{"key":"1072_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/BF00303087","volume":"277","author":"JH Deijnen Van","year":"1994","unstructured":"Van Deijnen JH, Van Suylichem PT, Wolters GH, Van Schilfgaarde R. Distribution of collagens type I, type III and type V in the pancreas of rat, dog, pig and man. Cell Tissue Res. 1994;277:115\u201321.","journal-title":"Cell Tissue Res"},{"key":"1072_CR20","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1163\/15685620260178418","volume":"13","author":"NA Nagata","year":"2002","unstructured":"Nagata NA, Inoue K, Tabata Y. Co-culture of extracellular matrix suppresses the cell death of rat pancreatic islets. J Biomater Sci Polym Ed. 2002;13:579\u201390.","journal-title":"J Biomater Sci Polym Ed"},{"key":"1072_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3727\/000000008783907125","volume":"17","author":"N Navarro-Alvarez","year":"2008","unstructured":"Navarro-Alvarez N, Rivas-Carrillo JD, Soto-Gutierrez A, Yuasa T, Okitsu T, Noguchi H, et al. Reestablishment of microenvironment is necessary to maintain in vitro and in vivo human islet function. Cell Transplant. 2008;17:111\u20139.","journal-title":"Cell Transplant"},{"key":"1072_CR22","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.2337\/diabetes.53.8.2034","volume":"53","author":"E Hammar","year":"2004","unstructured":"Hammar E, Parnaud G, Bosco D, Perriraz N, Maedler K, Donath M, et al. Extracellular matrix protects pancreatic beta-cells against apoptosis: role of short- and long-term signaling pathways. Diabetes. 2004;53:2034\u201341.","journal-title":"Diabetes"},{"key":"1072_CR23","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00125-002-0840-7","volume":"45","author":"F Ris","year":"2002","unstructured":"Ris F, Hammar E, Bosco D, Pilloud C, Maedler K, Donath M, et al. Impact of integrin-matrix matching and inhibition of apoptosis on the survival of purified human beta-cells in vitro. Diabetologia. 2002;45:841\u201350.","journal-title":"Diabetologia"},{"key":"1072_CR24","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.2337\/db06-0120","volume":"55","author":"T Kaido","year":"2006","unstructured":"Kaido T, Yebra M, Cirulli V, Rhodes C, Diaferia G, Montgomery AM. Impact of defined matrix interactions on insulin production by cultured human beta-cells: effect on insulin content, secretion, and gene transcription. Diabetes. 2006;55:2723\u20139.","journal-title":"Diabetes"},{"key":"1072_CR25","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.2337\/diabetes.51.12.3435","volume":"51","author":"GM Beattie","year":"2002","unstructured":"Beattie GM, Montgomery AMP, Lopez AD, Hao E, Perez B, Just ML, et al. A novel approach to increase human islet cell mass while preserving beta-cell function. Diabetes. 2002;51:3435\u20139.","journal-title":"Diabetes"},{"key":"1072_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0303-7207(93)90046-M","volume":"94","author":"C Lucas-Clerc","year":"1993","unstructured":"Lucas-Clerc C, Massart C, Campion JP, Launois B, Nicol M. Long-term culture of human pancreatic islets in an extracellular matrix: morphological and metabolic effects. Mol Cell Endocrinol. 1993;94:9\u201320.","journal-title":"Mol Cell Endocrinol"},{"key":"1072_CR27","first-page":"3382","volume":"27","author":"C Ricordi","year":"1995","unstructured":"Ricordi C, et al. Long-term in vivo function of human mantled islets obtained by incomplete pancreatic dissociation and purification. Transplant Proc. 1995;27:3382.","journal-title":"Transplant Proc"},{"key":"1072_CR28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0039-6060(99)70169-8","volume":"126","author":"FT Thomas","year":"1999","unstructured":"Thomas FT, Contreras JL, Bilbao G, Ricordi C, Curiel D, Thomas JM. Anoikis, extracellular matrix, and apoptosis factors in isolated cell transplantation. Surgery. 1999;126:299\u2013304.","journal-title":"Surgery"},{"key":"1072_CR29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1172\/JCI46177","volume":"122","author":"AF Ziolkowski","year":"2012","unstructured":"Ziolkowski AF, Popp SK, Freeman C, Parish CR, Simeonovic CJ. Heparan sulfate and heparanase play key roles in mouse beta cell survival and autoimmune diabetes. J Clin Invest. 2012;122:132\u201341.","journal-title":"J Clin Invest"},{"key":"1072_CR30","first-page":"621249","volume":"2013","author":"P Meda","year":"2013","unstructured":"Meda P. Protein-mediated interactions of pancreatic islet cells. Scientifica (Cairo). 2013;2013:621249.","journal-title":"Scientifica (Cairo)"},{"key":"1072_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nm1684","volume":"14","author":"HC Ott","year":"2008","unstructured":"Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, et al. Perfusion-decellularized matrix: using nature\u2019s platform to engineer a bioartificial heart. Nat Med. 2008;14:213\u201321.","journal-title":"Nat Med"},{"key":"1072_CR32","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/nm.2193","volume":"16","author":"HC Ott","year":"2010","unstructured":"Ott HC, Clippinger B, Conrad C, Schuetz C, Pomerantseva I, Ikonomou L, et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med. 2010;16:927\u201333.","journal-title":"Nat Med"},{"key":"1072_CR33","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/nprot.2014.097","volume":"9","author":"JP Guyette","year":"2014","unstructured":"Guyette JP, Gilpin SE, Charest JM, Tapias LF, Ren X, Ott HC. Perfusion decellularization of whole organs. Nat Protoc. 2014;9:1451\u201368.","journal-title":"Nat Protoc"},{"key":"1072_CR34","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/nbt.3354","volume":"33","author":"X Ren","year":"2015","unstructured":"\u2022\u2022 Ren X, et al. Engineering pulmonary vasculature in decellularized rat and human lungs. Nat Biotechnol. 2015;33:1097\u2013102. This study provides a technique to functionally revascularize a native decellularized organ.","journal-title":"Nat Biotechnol"},{"key":"1072_CR35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/SLA.0000000000001364","volume":"264","author":"A Peloso","year":"2016","unstructured":"\u2022\u2022 Peloso A, et al. The human pancreas as a source of protolerogenic extracellular matrix scaffold for a new-generation bioartificial endocrine pancreas. Ann Surg. 2016;264:169\u201379. This study describes a technique to use a decellularized human pancreas as native scaffold for bioengineering endocrine organ.","journal-title":"Ann Surg"},{"key":"1072_CR36","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.pan.2016.06.007","volume":"16","author":"Y Katsuki","year":"2016","unstructured":"Katsuki Y, Yagi H, Okitsu T, Kitago M, Tajima K, Kadota Y, et al. Endocrine pancreas engineered using porcine islets and partial pancreatic scaffolds. Pancreatology. 2016;16:922\u201330.","journal-title":"Pancreatology"},{"key":"1072_CR37","doi-asserted-by":"publisher","first-page":"5488","DOI":"10.1016\/j.biomaterials.2013.03.054","volume":"34","author":"SH Mirmalek-Sani","year":"2013","unstructured":"Mirmalek-Sani SH, Orlando G, McQuilling JP, Pareta R, Mack DL, Salvatori M, et al. Porcine pancreas extracellular matrix as a platform for endocrine pancreas bioengineering. Biomaterials. 2013;34:5488\u201395.","journal-title":"Biomaterials"},{"key":"1072_CR38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13036-018-0096-5","volume":"12","author":"H Yu","year":"2018","unstructured":"Yu H, Chen Y, Kong H, He Q, Sun H, Bhugul PA, et al. The rat pancreatic body tail as a source of a novel extracellular matrix scaffold for endocrine pancreas bioengineering. J Biol Eng. 2018;12:6.","journal-title":"J Biol Eng"},{"key":"1072_CR39","first-page":"S62","volume":"211","author":"C Claudius","year":"2010","unstructured":"Claudius C, et al. Bio-engineered endocrine pancreas based on decellularized pancreatic matrix and mesenchymal stem cell\/islet cell coculture. J Am Coll Surg. 2010;211:S62.","journal-title":"J Am Coll Surg"},{"key":"1072_CR40","doi-asserted-by":"publisher","first-page":"10452","DOI":"10.1038\/s41598-018-28857-1","volume":"8","author":"SD Sackett","year":"2018","unstructured":"Sackett SD, Tremmel DM, Ma F, Feeney AK, Maguire RM, Brown ME, et al. Extracellular matrix scaffold and hydrogel derived from decellularized and delipidized human pancreas. Sci Rep. 2018;8:10452.","journal-title":"Sci Rep"},{"key":"1072_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156053","volume":"11","author":"N Abualhassan","year":"2016","unstructured":"Abualhassan N, Sapozhnikov L, Pawlick RL, Kahana M, Pepper AR, Bruni A, et al. Lung-derived microscaffolds facilitate diabetes reversal after mouse and human intraperitoneal islet transplantation. PLoS One. 2016;11:e0156053.","journal-title":"PLoS One"},{"key":"1072_CR42","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.biomaterials.2017.05.033","volume":"138","author":"X Wang","year":"2017","unstructured":"Wang X, Wang K, Zhang W, Qiang M, Luo Y. A bilaminated decellularized scaffold for islet transplantation: structure, properties and functions in diabetic mice. Biomaterials. 2017;138:80\u201390.","journal-title":"Biomaterials"},{"key":"1072_CR43","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0142-9612(02)00319-8","volume":"24","author":"P Vos de","year":"2003","unstructured":"de Vos P, van Hoogmoed CG, van Zanten J, Netter S, Strubbe JH, Busscher HJ. Long-term biocompatibility, chemistry, and function of microencapsulated pancreatic islets. Biomaterials. 2003;24:305\u201312.","journal-title":"Biomaterials"},{"key":"1072_CR44","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3727\/000000004783983738","volume":"13","author":"P Vos de","year":"2004","unstructured":"de Vos P, de Haan BJ, de Haan A, van Zanten J, Faas MM. Factors influencing functional survival of microencapsulated islet grafts. Cell Transplant. 2004;13:515\u201324.","journal-title":"Cell Transplant"},{"key":"1072_CR45","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s00125-017-4524-8","volume":"61","author":"LA Llacua","year":"2018","unstructured":"Llacua LA, Faas MM, de Vos P. Extracellular matrix molecules and their potential contribution to the function of transplanted pancreatic islets. Diabetologia. 2018;61:1261\u201372.","journal-title":"Diabetologia"},{"key":"1072_CR46","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/term.2472","volume":"12","author":"LA Llacua","year":"2018","unstructured":"Llacua LA, de Haan BJ, de Vos P. Laminin and collagen IV inclusion in immunoisolating microcapsules reduces cytokine-mediated cell death in human pancreatic islets. J Tissue Eng Regen Med. 2018;12:460\u20137.","journal-title":"J Tissue Eng Regen Med"},{"key":"1072_CR47","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1089\/ten.tea.2007.0238","volume":"14","author":"LM Weber","year":"2008","unstructured":"Weber LM, Hayda KN, Anseth KS. Cell-matrix interactions improve beta-cell survival and insulin secretion in three-dimensional culture. Tissue Eng A. 2008;14:1959\u201368.","journal-title":"Tissue Eng A"},{"key":"1072_CR48","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1002\/jbm.a.35706","volume":"104","author":"A Llacua","year":"2016","unstructured":"Llacua A, de Haan BJ, Smink SA, de Vos P. Extracellular matrix components supporting human islet function in alginate-based immunoprotective microcapsules for treatment of diabetes. J Biomed Mater Res A. 2016;104:1788\u201396.","journal-title":"J Biomed Mater Res A"},{"key":"1072_CR49","doi-asserted-by":"crossref","unstructured":"Shridhar A, Gillies E, Amsden BG, Flynn LE. Composite bioscaffolds incorporating decellularized ECM as a cell-instructive component within hydrogels as in vitro models and cell delivery systems. In: Methods in Molecular Biology. Humana Press; 2017.","DOI":"10.1007\/7651_2017_36"},{"key":"1072_CR50","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.copbio.2013.05.004","volume":"24","author":"MM Coronel","year":"2013","unstructured":"Coronel MM, Stabler CL. Engineering a local microenvironment for pancreatic islet replacement. Curr Opin Biotechnol. 2013;24:900\u20138.","journal-title":"Curr Opin Biotechnol"},{"issue":"2","key":"1072_CR51","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s10047-018-1017-6","volume":"21","author":"Y Guo","year":"2018","unstructured":"Guo Y, Wu C, Xu L, Xu Y, Xiaohong L, Hui Z, et al. Vascularization of pancreatic decellularized scaffold with endothelial progenitor cells. J Artif Organs. 2018;21(2):230\u20137.","journal-title":"J Artif Organs"},{"key":"1072_CR52","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1177\/0885328217752859","volume":"32","author":"L Xu","year":"2018","unstructured":"Xu L, Guo Y, Huang Y, Xiong Y, Xu Y, Li X, et al. Constructing heparin-modified pancreatic decellularized scaffold to improve its re-endothelialization. J Biomater Appl. 2018;32:1063\u201370.","journal-title":"J Biomater Appl"},{"key":"1072_CR53","doi-asserted-by":"publisher","first-page":"5680","DOI":"10.1039\/C4CS00483C","volume":"44","author":"X Ren","year":"2015","unstructured":"Ren X, Feng Y, Guo J, Wang H, Li Q, Yang J, et al. Surface modification and endothelialization of biomaterials as potential scaffolds for vascular tissue engineering applications. Chem Soc Rev. 2015;44:5680\u2013742.","journal-title":"Chem Soc Rev"},{"key":"1072_CR54","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.biomaterials.2018.04.028","volume":"171","author":"H Park","year":"2018","unstructured":"Park H, Haque MR, Park JB, Lee KW, Lee S, Kwon Y, et al. Polymeric nano-shielded islets with heparin-polyethylene glycol in a non-human primate model. Biomaterials. 2018;171:164\u201377.","journal-title":"Biomaterials"},{"key":"1072_CR55","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1177\/0963689718754562","volume":"27","author":"JA Gebe","year":"2018","unstructured":"Gebe JA, Preisinger A, Gooden MD, D'Amico LA, Vernon RB. Local, controlled release in vivo of vascular endothelial growth factor within a subcutaneous scaffolded islet implant reduces early islet necrosis and improves performance of the graft. Cell Transplant, 963689718754562. 2018;27:531\u201341.","journal-title":"Cell Transplant"},{"key":"1072_CR56","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1172\/JCI118929","volume":"98","author":"Y Sun","year":"1996","unstructured":"Sun Y, Ma X, Zhou D, Vacek I, Sun AM. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest. 1996;98:1417\u201322.","journal-title":"J Clin Invest"},{"key":"1072_CR57","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1097\/01.tp.0000208610.75997.20","volume":"81","author":"D Dufrane","year":"2006","unstructured":"Dufrane D, Goebbels RM, Saliez A, Guiot Y, Gianello P. Six-month survival of microencapsulated pig islets and alginate biocompatibility in primates: proof of concept. Transplantation. 2006;81:1345\u201353.","journal-title":"Transplantation"},{"issue":"2","key":"1072_CR58","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/MOT.0b013e3283449dec","volume":"16","author":"RB Elliott","year":"2011","unstructured":"Elliott RB. Towards xenotransplantation of pig islets in the clinic. Curr Opin Organ Transplant. 2011;16(2):195\u2013200.","journal-title":"Curr Opin Organ Transplant"},{"key":"1072_CR59","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1126\/science.aan4187","volume":"357","author":"D Niu","year":"2017","unstructured":"Niu D, Wei HJ, Lin L, George H, Wang T, Lee IH, et al. Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9. Science. 2017;357:1303\u20137.","journal-title":"Science"},{"key":"1072_CR60","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1126\/science.aad1191","volume":"350","author":"L Yang","year":"2015","unstructured":"Yang L, Guell M, Niu D, George H, Lesha E, Grishin D, et al. Genome-wide inactivation of porcine endogenous retroviruses (PERVs). Science. 2015;350:1101\u20134.","journal-title":"Science"},{"key":"1072_CR61","doi-asserted-by":"publisher","first-page":"3572","DOI":"10.1038\/s41598-017-03913-4","volume":"7","author":"LW Buerck","year":"2017","unstructured":"Buerck LW, Schuster M, Oduncu FS, Baehr A, Mayr T, Guethoff S, et al. LEA29Y expression in transgenic neonatal porcine islet-like cluster promotes long-lasting xenograft survival in humanized mice without immunosuppressive therapy. Sci Rep. 2017;7:3572.","journal-title":"Sci Rep"},{"key":"1072_CR62","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature21070","volume":"542","author":"T Yamaguchi","year":"2017","unstructured":"\u2022\u2022 Yamaguchi T, et al. Interspecies organogenesis generates autologous functional islets. Nature. 2017;542:191\u20136. This study describes successful blastocyst complementation as alternative strategy to generate species-specific beta cells with therapeutic potential.","journal-title":"Nature"},{"key":"1072_CR63","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663\u201376.","journal-title":"Cell"},{"key":"1072_CR64","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/nbt1259","volume":"24","author":"KA D'Amour","year":"2006","unstructured":"D'Amour KA, Bang AG, Eliazer S, Kelly OG, Agulnick AD, Smart NG, et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol. 2006;24:1392\u2013401.","journal-title":"Nat Biotechnol"},{"key":"1072_CR65","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nbt1393","volume":"26","author":"E Kroon","year":"2008","unstructured":"Kroon E, Martinson LA, Kadoya K, Bang AG, Kelly OG, Eliazer S, et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol. 2008;26:443\u201352.","journal-title":"Nat Biotechnol"},{"key":"1072_CR66","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/nbt.3033","volume":"32","author":"A Rezania","year":"2014","unstructured":"Rezania A, Bruin JE, Arora P, Rubin A, Batushansky I, Asadi A, et al. Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nat Biotechnol. 2014;32:1121\u201333.","journal-title":"Nat Biotechnol"},{"key":"1072_CR67","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2014.09.040","volume":"159","author":"FW Pagliuca","year":"2014","unstructured":"Pagliuca FW, Millman JR, G\u00fcrtler M, Segel M, van Dervort A, Ryu JH, et al. Generation of functional human pancreatic beta cells in vitro. Cell. 2014;159:428\u201339.","journal-title":"Cell"},{"key":"1072_CR68","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1634\/stemcells.2006-0761","volume":"25","author":"J Jiang","year":"2007","unstructured":"Jiang J, Au M, Lu K, Eshpeter A, Korbutt G, Fisk G, et al. Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells. 2007;25:1940\u201353.","journal-title":"Stem Cells"},{"key":"1072_CR69","doi-asserted-by":"publisher","first-page":"31601","DOI":"10.1074\/jbc.M806597200","volume":"283","author":"K Tateishi","year":"2008","unstructured":"Tateishi K, He J, Taranova O, Liang G, D'Alessio AC, Zhang Y. Generation of insulin-secreting islet-like clusters from human skin fibroblasts. J Biol Chem. 2008;283:31601\u20137.","journal-title":"J Biol Chem"},{"key":"1072_CR70","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nprot.2006.71","volume":"1","author":"IS Schroeder","year":"2006","unstructured":"Schroeder IS, Rolletschek A, Blyszczuk P, Kania G, Wobus AM. Differentiation of mouse embryonic stem cells to insulin-producing cells. Nat Protoc. 2006;1:495\u2013507.","journal-title":"Nat Protoc"},{"key":"1072_CR71","doi-asserted-by":"publisher","first-page":"13426","DOI":"10.1073\/pnas.1007884107","volume":"107","author":"Z Alipio","year":"2010","unstructured":"Alipio Z, Liao W, Roemer EJ, Waner M, Fink LM, Ward DC, et al. Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells. Proc Natl Acad Sci U S A. 2010;107:13426\u201331.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1072_CR72","doi-asserted-by":"publisher","first-page":"15768","DOI":"10.1073\/pnas.0906894106","volume":"106","author":"R Maehr","year":"2009","unstructured":"Maehr R, Chen S, Snitow M, Ludwig T, Yagasaki L, Goland R, et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci U S A. 2009;106:15768\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1072_CR73","doi-asserted-by":"publisher","first-page":"11463","DOI":"10.1038\/ncomms11463","volume":"7","author":"JR Millman","year":"2016","unstructured":"Millman JR, Xie C, van Dervort A, G\u00fcrtler M, Pagliuca FW, Melton DA. Generation of stem cell-derived beta-cells from patients with type 1 diabetes. Nat Commun. 2016;7:11463.","journal-title":"Nat Commun"},{"key":"1072_CR74","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nbt.3860","volume":"35","author":"GG Gornalusse","year":"2017","unstructured":"Gornalusse GG, Hirata RK, Funk SE, Riolobos L, Lopes VS, Manske G, et al. HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells. Nat Biotechnol. 2017;35:765\u201372.","journal-title":"Nat Biotechnol"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11892-018-1072-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-018-1072-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-018-1072-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T19:19:41Z","timestamp":1569957581000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11892-018-1072-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,2]]},"references-count":74,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["1072"],"URL":"https:\/\/doi.org\/10.1007\/s11892-018-1072-7","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,2]]},"assertion":[{"value":"2 October 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Antonio Citro declares no conflict of interest. Harald C. Ott is founder and stockholder of IVIVA Medical Inc., a bioengineering company. This relationship had no effect on the content of this article. Also, Dr. Ott has a patent pending on bioartificial pancreas.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"122"}}